Flow cytometric immunophenotyping for hematologic neoplasms.

By F. Craig, K. Foon. Blood, 2008

671 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis (2015, neutral): “Signaling phenotypes define functionally distinct subpopulations Surface markers have become standard tools for clinical diagnosis and monitoring of blood neoplasia (Craig and Foon, 2008).”
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes (2012, background): “In the later situation, usage of a full antibody panel is recommended for the characterization and diagnostic classification of the suspected cells, using several (common) backbone markers for reliable and reproducible identification of the target cells in each multicolor combination of the antibody”
Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. (2011, background): “Flow cytometry is an important clinical tool for objectively accessing hematologic malignancies, whereby abnormal cells are identified through the aberrant expression of surface markers.(44) Our results will be most”